- In Vivo Metabolic
Regulation and Obesity - Islet Development,
Biology, and
Immunology - Complications of
Diabetes - Oxidative stress
- Signal transduction
and Gene Regulation - Clinical Research
- Translational Research
Prevention, Control, and Translation
Vanderbilt University and Meharry Medical College (MMC) have joined talents and resources in our Prevention and Control (P&C) Core, which promotes innovative diabetes-related translational research. Dr. Tom Elasy, the Medical Director of the Vanderbilt Eskind Diabetes Clinic, is the Director of the P&C Core of the Vanderbilt DRTC.
The P&C Core consists of two units, a Clinical Outcomes & Behavioral Science (COBS) Unit, co-directed by Drs. James Pichert and David Schlundt, and a Community Outreach & Health Disparities (COHD) Unit, directed by Dr. Margaret Hargreaves. The P&C Core and its two units provide services to investigators with externally funded, diabetes-related translational research addressing the following areas: innovations in care, community engagement, culturally-sensitive/competent interventions, clinical trials, quality improvement, quality assurance, health services research, clinical and psychosocial epidemiology, environmental studies, and community-based participatory research. A continuing focus of our work is understanding and reducing racial and ethnic health disparities. In addition to supporting externally funded research, the Core supports translational research funded through the Pilot and Feasibility mechanism. In addition, Dr. Hargreaves is focused on health disparities and has considerable experience in the development and utilization of community coalitions and expertise in nutrition/health assessment, behavioral intervention, and community coalition building.
For information about the Prevention and Control Core, contact Dr. Tom Elasy.
Other NIH-funded DRTCs with Prevention and Control Programs include Albert Einstein College of Medicine, University of Chicago, University of Michigan, and Washington University.
